TY - JOUR
T1 - Chronic Exposure of Gingival Fibroblasts to TLR2 or TLR4 Agonist Inhibits Osteoclastogenesis but Does Not Affect Osteogenesis
AU - Karlis, Gerasimos D.
AU - Schöningh, Emily
AU - Jansen, Ineke D.C.
AU - Schoenmaker, Ton
AU - Hogervorst, Jolanda M.A.
AU - van Veen, Henk A.
AU - Moonen, Carolyn G.J.
AU - Łagosz-Ćwik, Katarzyna B.
AU - Forouzanfar, Tim
AU - de Vries, Teun J.
N1 - Funding Information:
We thank the class of 2018 of the Cell Biology and Physiology Lab course from Amsterdam University College for collecting some of the data under the supervision of co-authors (IJ, TS, TV, HV, and JH). The educational and pedagogical set-up of this particular 2018 class was recently published (16). Mick Roumen, a student from Amsterdam University College is acknowledged for performing the osteogenesis PCRs. We also acknowledge Petra Henning and Ali Kassem from the Department of Internal Medicine and Clinical Nutrition at Institute for Medicine, Sahlgrenska Academy at the University of Gothenburg, Sweden for their valuable advice regarding TLR2 and TLR4 agonists. K?-? received funding from Erasmus travel grant allowing experiments to be performed in Amsterdam (ACTA). Funding. This research was sponsored by Institutional Funds.
Publisher Copyright:
© Copyright © 2020 Karlis, Schöningh, Jansen, Schoenmaker, Hogervorst, van Veen, Moonen, Łagosz-Ćwik, Forouzanfar and de Vries.
PY - 2020/7/23
Y1 - 2020/7/23
N2 - Chronic exposure to periodontopathogenic bacteria such as Porphyromonas gingivalis and the products of these bacteria that interact with the cells of the tooth surrounding tissues can ultimately result in periodontitis. This is a disease that is characterized by inflammation-related alveolar bone degradation by the bone-resorbing cells, the osteoclasts. Interactions of bacterial products with Toll-like receptors (TLRs), in particular TLR2 and TLR4, play a significant role in this chronic inflammatory reaction, which possibly affects osteoclastic activity and osteogenic capacity. Little is known about how chronic exposure to specific TLR activators affects these two antagonistic activities. Here, we studied the effect of TLR activation on gingival fibroblasts (GF), cells that are anatomically close to infiltrating bacterial products in the mouth. These were co-cultured with naive osteoclast precursor cells (i.e., monocytes), as part of the peripheral blood mononuclear cells (PBMCs). Activation of GF co-cultures (GF + PBMCs) with TLR2 or TLR4 agonists resulted in a weak reduction of the osteoclastogenic potential of these cultures, predominantly due to TLR2. Interestingly, chronic exposure, especially to TLR2 agonist, resulted in increased release of TNF-α at early time points. This effect, was reversed at later time points, thus suggesting an adaptation to chronic exposure. Monocyte cultures primed with M-CSF + RANKL, led to the formation of bone-resorbing osteoclasts, irrespective of being activated with TLR agonists. Late activation of these co-cultures with TLR2 and with TLR4 agonists led to a slight decrease in bone resorption. Activation of GF with TLR2 and TLR4 agonists did not affect the osteogenic capacity of the GF cells. In conclusion, chronic exposure leads to diverse reactions; inhibitory with naive osteoclast precursors, not effecting already formed (pre-)osteoclasts. We suggest that early encounter of naive monocytes with TLR agonists may result in differentiation toward the macrophage lineage, desirable for clearing bacterial products. Once (pre-)osteoclasts are formed, these cells may be relatively insensitive for direct TLR stimulation. Possibly, TLR activation of periodontal cells indirectly stimulates osteoclasts, by secreting osteoclastogenesis stimulating inflammatory cytokines.
AB - Chronic exposure to periodontopathogenic bacteria such as Porphyromonas gingivalis and the products of these bacteria that interact with the cells of the tooth surrounding tissues can ultimately result in periodontitis. This is a disease that is characterized by inflammation-related alveolar bone degradation by the bone-resorbing cells, the osteoclasts. Interactions of bacterial products with Toll-like receptors (TLRs), in particular TLR2 and TLR4, play a significant role in this chronic inflammatory reaction, which possibly affects osteoclastic activity and osteogenic capacity. Little is known about how chronic exposure to specific TLR activators affects these two antagonistic activities. Here, we studied the effect of TLR activation on gingival fibroblasts (GF), cells that are anatomically close to infiltrating bacterial products in the mouth. These were co-cultured with naive osteoclast precursor cells (i.e., monocytes), as part of the peripheral blood mononuclear cells (PBMCs). Activation of GF co-cultures (GF + PBMCs) with TLR2 or TLR4 agonists resulted in a weak reduction of the osteoclastogenic potential of these cultures, predominantly due to TLR2. Interestingly, chronic exposure, especially to TLR2 agonist, resulted in increased release of TNF-α at early time points. This effect, was reversed at later time points, thus suggesting an adaptation to chronic exposure. Monocyte cultures primed with M-CSF + RANKL, led to the formation of bone-resorbing osteoclasts, irrespective of being activated with TLR agonists. Late activation of these co-cultures with TLR2 and with TLR4 agonists led to a slight decrease in bone resorption. Activation of GF with TLR2 and TLR4 agonists did not affect the osteogenic capacity of the GF cells. In conclusion, chronic exposure leads to diverse reactions; inhibitory with naive osteoclast precursors, not effecting already formed (pre-)osteoclasts. We suggest that early encounter of naive monocytes with TLR agonists may result in differentiation toward the macrophage lineage, desirable for clearing bacterial products. Once (pre-)osteoclasts are formed, these cells may be relatively insensitive for direct TLR stimulation. Possibly, TLR activation of periodontal cells indirectly stimulates osteoclasts, by secreting osteoclastogenesis stimulating inflammatory cytokines.
KW - bone resorption
KW - chronic inflammation
KW - innate immunity
KW - osteoblasts
KW - osteoclasts
KW - periodontitis
KW - TNF-α
KW - toll-like receptors
UR - http://www.scopus.com/inward/record.url?scp=85089068302&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2020.01693
DO - 10.3389/fimmu.2020.01693
M3 - Article
C2 - 32793243
AN - SCOPUS:85089068302
SN - 1664-3224
VL - 11
JO - Frontiers in Immunology: Molecular Innate Immunity
JF - Frontiers in Immunology: Molecular Innate Immunity
M1 - 1693
ER -